AI-Driven De Novo Design of Ultra Long-Acting GLP-1 Receptor Agonists.

Adv Sci (Weinh) · 2025 · PMC12561408 · PMID 40787887

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

While serum TC showed a decreasing trend in the Semaglutide, D13, D41, and D44, the difference was not statistically significant (Figure 5F ). 2.7 Sequence and Structure Analysis of GLP‐1RAs To gain insights into the sequence and structural characteristics of GLP‐1RAs associated with longer half‐life and improved efficacy, we performed a comprehensive analysis of sequence, structure, and evolutionary relationships.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.